Steps Towards Establishing a New Community-led Initiative Focusing on Immune Challenges

The CLL Advocates Network (CLLAN) is proud to announce that it is setting up a new community-led initiative to address the immune challenges people living with chronic lymphocytic leukaemia (CLL) face.

We aim to build on the insights from our 2023 white paper, “Compromised: Uncovering the Immune-Related Challenges Facing People with Chronic Lymphocytic Leukaemia”  funded by AstraZeneca, and establish a new community-led initiative that will translate these findings into tangible improvements for people living with CLL.

The first step towards this new initiative is a series of workshops to be held in early July 2024. These workshops will offer a unique platform for stakeholders from CLL clinical and advocacy communities worldwide to come together develop a clear, shared vision for this new initiative and identify practical policy recommendations for the group to drive forward.

This initiative is multi sponsored and grant funded currently by two funders, AstraZeneca and Takeda. CLLAN is interested in securing funding from additional industry partners for future phases of this initiative, please get in touch if you would like to learn more.

CLLAN is excited to bring together the global CLL community and drive real change for people living with immune challenges and CLL. More information will be published on the outcomes of these workshops and the launch of this new community-led initiative.

Together, we can overcome immune challenges and enhance the quality of life for all people affected by CLL